Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406549 · ClinicalTrials.gov registry record
Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus
A clinical trial, sponsored by Solventum US.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT00406549 is a clinical trial that has completed, run by Solventum US. The registered enrollment target is 2,000 participants.
The verdict
NCT00406549 has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
To establish the clinical test performance characteristics of sensitivity, specificity and predictive values for direct detection of nasal Staphylococcus aureus colonization against clinical microbiology laboratory culture methods.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2006-12 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00406549
The ClinicalTrials.gov registry entry for NCT00406549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00406549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00406549 about?
NCT00406549 is a clinical study titled "Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus". To establish the clinical test performance characteristics of sensitivity, specificity and predictive values for direct detection of nasal Staphylococcus aureus colonization against clinical microbiology laboratory culture methods.
What is the current status of trial NCT00406549?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2006-12. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00406549?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.